Manchester Royal Eye Hospital administers its first gene therapy treatment
MREH is trialling gene therapy, in collaboration with Saint Mary’s Hospital, for patients with a rare genetic eye condition, x-linked retinitis pigmentosa (XLRP).
Read moreResearch and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
New research highlights research priorities for young people with rheumatic disease
A national study is the first of its kind to present young people’s priorities in rheumatology research, suggesting a need for a greater focus on basic science and psychosocial research.
Read more
Newborn Intensive Care Unit has recruited the first two UK patients to multi-centre European Vancomycin study
The study aims to develop optimal dosing and monitoring regimen of the antibiotic vancomycin for neonates and infants under 3 months old with late onset sepsis caused by gram-positive microorganisms.
Read more
Are you working in, supporting, or interested in working in research?
Come along to NIHR CRN:GM Research Delivery Day and meet NIHR Clinical Research Network Greater Manchester staff. Open to research and non-research staff interested in getting involved in research
Read more
Research Programme Managers’ Network
The RPMN is a peer support network where central issues in research grant management are discussed, and as a collective, members can make a meaningful contribution to research innovation.
Read more
First in Europe to recruit patient to Sickle Cell Disease study
The study aims to research the effect of study drug GBT440, in increasing red blood cells and reducing the severity of symptoms of sickle cell disease compared to current treatment options
Read more
More patients accessing new treatments in Greater Manchester
More than 40,700 participants were given access to new and better treatments through participation in clinical research in Greater Manchester in the past year, according to figures published today.
Read more
CMFT appoints Director to manage intellectual property portfolio
Kay Callaghan joins as Director of Intellectual Property (IP) and Business Partnerships to unlock potential for new technologies to deliver high quality care, drive efficiencies and generate income.
Read more
